Literature DB >> 26221194

What's New in Prostate Cancer Research? Highlights of GU-ASCO 2015.

Anil Kapoor1.   

Abstract

Entities:  

Year:  2015        PMID： 26221194      PMCID： PMC4497355          DOI： 10.5489/cuaj.2994

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  1 in total

1.  Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

Authors:  Maha Hussain; Catherine M Tangen; Celestia Higano; Paul F Schelhammer; James Faulkner; E David Crawford; George Wilding; Atif Akdas; Eric J Small; Bryan Donnelly; Gary MacVicar; Derek Raghavan
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544
  1 in total
  1 in total

1.  Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy.

Authors:  Ying-Li Lin; Qiu-Kui Deng; Yu-Hao Wang; Xing-Li Fu; Jian-Guo Ma; Wen-Ping Li
Journal:  Med Sci Monit       Date:  2015-12-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.